Trial Profile
A Dose Ranging Study of the Effects of Macroflux PTH Compared With Macroflux Placebo and FORTEO in Postmenopausal Women With Osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary) ; Teriparatide
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Zosano Pharma
- 01 Jan 2010 Results published in Journal of Clinical Endocrinology and Metabolism.
- 10 Nov 2009 Primary endpoint 'Lumbar spine bone mineral density' has been met.
- 10 Nov 2009 Results have been published in the current issue of the Journal of Clinical Endocrinology and Metabolism. The article is currently available online and will be in the January 2010 issue; announced by Zosano in a media release.